- Home
- Publications
- Publication Search
- Publication Details
Title
Management of medically refractory prolactinoma
Authors
Keywords
Prolactin, Prolactinoma, Dopamine, Resistance, Bromocriptine, Cabergoline
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 117, Issue 3, Pages 421-428
Publisher
Springer Nature
Online
2013-10-21
DOI
10.1007/s11060-013-1270-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temozolomide in the management of dopamine agonist-resistant prolactinomas
- (2012) B. C. Whitelaw et al. CLINICAL ENDOCRINOLOGY
- Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
- (2012) Laurent Vroonen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients
- (2012) V. Primeau et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Heart Valve Disease among Patients with Hyperprolactinemia: A Nationwide Population-Based Cohort Study
- (2012) Charlotte Steffensen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prolactinoma in pregnancy
- (2011) Mark E. Molitch BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinsonʼs Disease and Hyperprolactinaemia
- (2011) Gianluca Trifirò et al. DRUG SAFETY
- Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels
- (2011) Satoko Shimazu et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia
- (2010) Elena Valassi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior
- (2010) Zhe Bao Wu et al. JOURNAL OF NEURO-ONCOLOGY
- Invasive Giant Prolactinoma with Loss of Therapeutic Response to Cabergoline: Expression of Angiogenic Markers
- (2009) María Susana Mallea-Gil et al. ENDOCRINE PATHOLOGY
- Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients
- (2009) Etienne Delgrange et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review
- (2009) L. A. Behan et al. Pituitary
- Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas
- (2008) Alessandra Fusco et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
- (2008) Masami Ono et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists
- (2008) Vanessa Q. Passos et al. NEUROENDOCRINOLOGY
- Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
- (2008) M Filopanti et al. PHARMACOGENOMICS JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now